Bio

Matthew Latham practice focuses on mergers and acquisitions and private equity transactions. He has represented Australian and offshore acquirers and targets in a number of acquisitions, divestitures, take-private transactions, buyouts, and joint ventures. He also advises clients on various corporate-related matters, including directors' duties, corporate governance, and disclosure. Matt has recently advised Australian Health Management in its A$367 million demutualisation and sale to Medibank Private; a consortium consisting of HarbourVest Partners, Paul Capital Partners, Pantheon Ventures, and Partners Group in its A$837 million take-private of Macquarie Capital Group Alliance; and Bear Stearns Private Equity in its A$115 take-private of Macquarie Private Capital Group. Matt has published a number of articles and is a frequent speaker on mergers and acquisitions, private equity, and directors' duties.